RADNET INC (RDNT) Stock Fundamental Analysis
NASDAQ:RDNT - Nasdaq - US7504911022 - Common Stock - Currency: USD
We assign a fundamental rating of 4 out of 10 to RDNT. RDNT was compared to 102 industry peers in the Health Care Providers & Services industry. RDNT has only an average score on both its financial health and profitability. While showing a medium growth rate, RDNT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
RDNT had positive earnings in the past year.
RDNT had a positive operating cash flow in the past year.
RDNT had positive earnings in 4 of the past 5 years.
Each year in the past 5 years RDNT had a positive operating cash flow.
1.2 Ratios
RDNT has a Return On Assets (-0.97%) which is comparable to the rest of the industry.
RDNT has a Return On Equity of -3.60%. This is comparable to the rest of the industry: RDNT outperforms 49.02% of its industry peers.
RDNT's Return On Invested Capital of 2.38% is in line compared to the rest of the industry. RDNT outperforms 46.08% of its industry peers.
The Average Return On Invested Capital over the past 3 years for RDNT is significantly below the industry average of 9.50%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.97% | ||
| ROE | -3.6% | ||
| ROIC | 2.38% |
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
1.3 Margins
In the last couple of years the Profit Margin of RDNT has declined.
RDNT has a Operating Margin (4.38%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of RDNT has remained more or less at the same level.
With a Gross Margin value of 22.61%, RDNT perfoms like the industry average, outperforming 48.04% of the companies in the same industry.
RDNT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.38% | ||
| PM (TTM) | N/A | ||
| GM | 22.61% |
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), RDNT is destroying value.
The number of shares outstanding for RDNT remains at a similar level compared to 1 year ago.
RDNT has more shares outstanding than it did 5 years ago.
RDNT has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 1.82 indicates that RDNT is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.82, RDNT is in line with its industry, outperforming 44.12% of the companies in the same industry.
RDNT has a debt to FCF ratio of 12.96. This is a negative value and a sign of low solvency as RDNT would need 12.96 years to pay back of all of its debts.
RDNT's Debt to FCF ratio of 12.96 is in line compared to the rest of the industry. RDNT outperforms 44.12% of its industry peers.
RDNT has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
RDNT's Debt to Equity ratio of 1.10 is on the low side compared to the rest of the industry. RDNT is outperformed by 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.1 | ||
| Debt/FCF | 12.96 | ||
| Altman-Z | 1.82 |
ROIC/WACC0.27
WACC8.89%
2.3 Liquidity
A Current Ratio of 2.01 indicates that RDNT has no problem at all paying its short term obligations.
The Current ratio of RDNT (2.01) is better than 74.51% of its industry peers.
A Quick Ratio of 2.01 indicates that RDNT has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.01, RDNT is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.01 | ||
| Quick Ratio | 2.01 |
3. Growth
3.1 Past
RDNT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -67.69%.
Measured over the past years, RDNT shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.79% on average per year.
RDNT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.76%.
Measured over the past years, RDNT shows a quite strong growth in Revenue. The Revenue has been growing by 9.65% on average per year.
EPS 1Y (TTM)-67.69%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%-600%
Revenue 1Y (TTM)12.76%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%9.19%
3.2 Future
The Earnings Per Share is expected to grow by 6.20% on average over the next years.
RDNT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.22% yearly.
EPS Next Y-48.3%
EPS Next 2Y6.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.34%
Revenue Next 2Y8.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 269.57, the valuation of RDNT can be described as expensive.
61.76% of the companies in the same industry are cheaper than RDNT, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of RDNT to the average of the S&P500 Index (25.82), we can say RDNT is valued expensively.
With a Price/Forward Earnings ratio of 79.66, RDNT can be considered very expensive at the moment.
RDNT's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. RDNT is more expensive than 60.78% of the companies in the same industry.
RDNT is valuated expensively when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 269.57 | ||
| Fwd PE | 79.66 |
4.2 Price Multiples
RDNT's Enterprise Value to EBITDA is on the same level as the industry average.
RDNT's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 54.49 | ||
| EV/EBITDA | 16.07 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)16.06
EPS Next 2Y6.2%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for RDNT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
56.61
-0.16 (-0.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners88.9%
Inst Owner Change9.5%
Ins Owners10.8%
Ins Owner Change1.2%
Market Cap4.25B
Analysts86.67
Price Target73.1 (29.13%)
Short Float %11.32%
Short Ratio7.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-77.8%
Min EPS beat(2)-161.6%
Max EPS beat(2)5.99%
EPS beat(4)2
Avg EPS beat(4)-35.08%
Min EPS beat(4)-161.6%
Max EPS beat(4)20.87%
EPS beat(8)6
Avg EPS beat(8)178.25%
EPS beat(12)7
Avg EPS beat(12)117.98%
EPS beat(16)9
Avg EPS beat(16)-190%
Revenue beat(2)2
Avg Revenue beat(2)2.78%
Min Revenue beat(2)1.29%
Max Revenue beat(2)4.27%
Revenue beat(4)4
Avg Revenue beat(4)2.9%
Min Revenue beat(4)1.29%
Max Revenue beat(4)4.27%
Revenue beat(8)8
Avg Revenue beat(8)1.8%
Revenue beat(12)10
Avg Revenue beat(12)1.98%
Revenue beat(16)12
Avg Revenue beat(16)0.96%
PT rev (1m)-4.87%
PT rev (3m)-16.83%
EPS NQ rev (1m)-12.38%
EPS NQ rev (3m)7.73%
EPS NY rev (1m)-27.04%
EPS NY rev (3m)-50.77%
Revenue NQ rev (1m)0.2%
Revenue NQ rev (3m)-1.18%
Revenue NY rev (1m)0.81%
Revenue NY rev (3m)-1.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 269.57 | ||
| Fwd PE | 79.66 | ||
| P/S | 2.27 | ||
| P/FCF | 54.49 | ||
| P/OCF | 16.5 | ||
| P/B | 4.73 | ||
| P/tB | 42.07 | ||
| EV/EBITDA | 16.07 |
EPS(TTM)0.21
EY0.37%
EPS(NY)0.71
Fwd EY1.26%
FCF(TTM)1.04
FCFY1.84%
OCF(TTM)3.43
OCFY6.06%
SpS24.92
BVpS11.97
TBVpS1.35
PEG (NY)N/A
PEG (5Y)16.06
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.97% | ||
| ROE | -3.6% | ||
| ROCE | 2.9% | ||
| ROIC | 2.38% | ||
| ROICexc | 3.19% | ||
| ROICexgc | 5.13% | ||
| OM | 4.38% | ||
| PM (TTM) | N/A | ||
| GM | 22.61% | ||
| FCFM | 4.17% |
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
ROICexc(3y)3.61%
ROICexc(5y)3.42%
ROICexgc(3y)6.03%
ROICexgc(5y)5.63%
ROCE(3y)3.6%
ROCE(5y)3.56%
ROICexcg growth 3Y-3.51%
ROICexcg growth 5Y-1.27%
ROICexc growth 3Y-4.28%
ROICexc growth 5Y-1.4%
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.1 | ||
| Debt/FCF | 12.96 | ||
| Debt/EBITDA | 3.48 | ||
| Cap/Depr | 89.2% | ||
| Cap/Sales | 9.6% | ||
| Interest Coverage | 0.97 | ||
| Cash Conversion | 90.9% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.01 | ||
| Quick Ratio | 2.01 | ||
| Altman-Z | 1.82 |
F-Score5
WACC8.89%
ROIC/WACC0.27
Cap/Depr(3y)97.03%
Cap/Depr(5y)109.5%
Cap/Sales(3y)9.85%
Cap/Sales(5y)9.84%
Profit Quality(3y)1105%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.69%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%-600%
EPS Next Y-48.3%
EPS Next 2Y6.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.76%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%9.19%
Revenue Next Year7.34%
Revenue Next 2Y8.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.09%
EBIT growth 3Y5.38%
EBIT growth 5Y8.53%
EBIT Next Year109.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y98.28%
FCF growth 3Y90.52%
FCF growth 5Y8.35%
OCF growth 1Y44.54%
OCF growth 3Y15.95%
OCF growth 5Y17.44%